期刊文献+

精神分裂症患者生活满意度相关影响因素分析 被引量:5

Relevant factors influencing life satisfaction of patients with schizophrenia
暂未订购
导出
摘要 目的探讨精神分裂症患者生活满意度的相关影响因素。为临床干预提供依据。方法将315例精神分裂症患者根据精神分裂症患者生活质量量表评分分为两组,观察组126例,对照组189例,对两组的病历资料进行回顾性分析。结果单因素分析显示,两组性别、文化程度、婚姻状况、家庭年收入、家庭关怀及应用新型抗精神病药物比率比较差异有显著性(P〈0.05或0.01);Logistic回归分析显示,性别、婚姻状况是影响精神分裂症患者生活满意度的独立危险因素(P〈0.05),家庭关怀、应用新型抗精神病药物则是独立保护性因素(P〈0.05)。结论精神分裂症患者生活满意度的影响因素较多,临床应首选新型抗精神病药物治疗,同时针对诸多影响因素进行心理干预,从而提高患者的治疗依从性和临床疗效,提高生活质量和生活满意度。 Objective To explore relevant factors influencing life satisfaction of patients with schizophrenia in order to provide basis for clinical intervention. Methods A total of 315 schizophrenics were assigned to observation (n=126) and control group (n=189) according to their score of the Schizophrenia Quality of Life Scale (SQLS), their case history data analyzed retrospectively. Results Single factor analysis showed that there were significant group differences in gender, educational level, marital status, family annual income, family concern and the ratio of utilizing novel antipsyhotics (P^0.05 or 0.01) ; Logistic regression analysis showed that gender and marital status were independent risk factors influencing life satisfaction of patients with schizophrenia (P〈0.05) and family concern and novel antipsyhotics independent protective factors (P〈0. 05). Conclusion Factors influencing life satisfaction of patients with schizophrenia are more, novel antipsyhotics treatment should be first choice clinically, mental interventions be carried out according to influencing factors, thereby treatment compliance and efficacy raised and quality of life and life satisfaction improved.
出处 《临床心身疾病杂志》 CAS 2012年第6期544-546,共3页 Journal of Clinical Psychosomatic Diseases
关键词 精神分裂症 生活满意度 相关因素 生活质量 精神分裂症患者生活质量量表 Schizophrenia life satisfaction relevant factor quality of life SQLS
  • 相关文献

参考文献9

  • 1Tan BL. Profile of cognitive problems in schizophrenia and implications for vocational functioning[J]. Aust Occup Ther .l, 2009 ,56(4) :220.
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准[M].第3版.济南:山东科学技术出版社,2001:75-77.
  • 3Luo N, Seng BK, Xie F, et al. Psychometric evaluation o{ the Schizophrenia Quality of Life Scale (SQLS) in Eng- lish- and Chinese-speaking Asians in Singapore [J]. Qual Life Res, 2008, 17(1):115.
  • 4van den Heuvel MP, Kahn RS. Abnormal brain wiring as a pathogenetic mechanism in schizophrenia[J]. Biol Psy chiatry, 2011, 70(12):1 107.
  • 5Coyle JT. MicroRNAs suggest a new mechanism for al tered brain gene expression in schizophrenia[J]. Proc Natl Acad Sci USA, 2009, 106(9):2 975.
  • 6Mendrek A, Stip E. Sexual dimorphism in schizophreni a: is there a need for gender-based protocols? [J]. Expert Rev Neurother, 2011, 11(7):951.
  • 7Chien WT, Lee IY. The schizophrenia care management program for family caregivers of Chinese patients with schiz- ophrenia[J]. Psychiatr Serv, 2010, 61(3) :317.
  • 8de Haan S, Liu X. ChLorpromazine dose {or people with schizophrenia[J]. Schizophr Bull, 2009, 35(3):491.
  • 9Fijal BA, Stauffer VL, Kinon BJ, et al. Analysis of gene variants previously associated with iloperidone response in patients with schizophrenia who are treated with risperi done[J]. J Clin Psychiatry, 2012, 73(3):367.

共引文献489

同被引文献42

  • 1薛殿凯,李爱平.阅读治疗在精神科健康教育中的应用[J].中华护理杂志,2004,39(1):20-22. 被引量:24
  • 2王学义,马文有,孙贺祥,张素花,张宝廷,彭精芬.改良式森田疗法应用于慢性精神分裂症的对照研究[J].中国健康心理学杂志,2004,12(4):253-256. 被引量:9
  • 3汪向东.心理卫生评定量表手册[M]增订版[M].北京:中国心理卫生杂志出版社,1999.120-129.
  • 4Yoshino T,Nisijima K,Shioda K,et al.Perospirone,a novel atypical antipsychotic drug,potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex[J].Neurosci Lett,2004,364(1):16.
  • 5太原浩一.森田疗法与新森田疗法[M]{H}北京:人民卫生出版社,199769-73.
  • 6汪向东;王希林;马弘.心理卫生评定量表手册[M]北京:中国心理卫生杂志社,199978-318.
  • 7Morosini PL,Magliano L,Brambilla L. Development,reliabili-ty and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale(SOFAS)to assess routine social functioning[J].{H}Acta Psychiatrica Scandinavica,2000,(04):323-329.
  • 8Jung H,Hwang S,Yi J. Life satisfaction,psychopatholo-gy and functional level in chronic schizophrenia undergoing an-tipsychotic treatment[J].{H}European Neuropsychopharmacology,2009.S514.
  • 9Ciudad A,San L,Bernardo M. Relapse and therapeutic in-terventions in a 1-year observational cohort study of nonadher-ent outpatients with schizophrenia[J].Prog Neuropsychophar-macol Biol Psychiatry,2012,(02):245-250.
  • 10AnstettRE,PooleSR.Bibliotherapyanadjuncttocareofpatientswithproblemsofliving[J].JFamPract,1983,17(5):845-853.

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部